Matches 1 - 23 out of 23


Match Document Document Title
US20120101427 NOVEL PHOTOSENSITIZER FORMULATIONS FOR ORAL ADMINISTRATION  
The present invention provides novel drug formulations for oral administration for diverse medical applications including anticancer, antimetastatic, antibacterial, antifungal, antiprotozoic,...
US20130149277 PTEROSTILBENE AND PVP GRAPE JUICE EXTRACT COMBINATION FOR TREATMENT OF METABOLIC, VASCULAR, AND NEURODEGENERATIVE DISORDERS  
A pharmaceutical composition is provided comprising a therapeutically effective amount of pterostilbene, a therapeutically effective amount of a polyphenolic-PVP extract of grape juice, and a...
US20110142789 Compositions and Methods for the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis  
Compositions and methods for diagnosis and treatment of ALS are provided.
US20130189219 N-TERMINALLY CHEMICALLY MODIFIED PROTEIN COMPOSITIONS AND METHODS  
Provided herein are methods and compositions relating to the attachment of water soluble polymers to proteins. Provided are novel methods for N-terminally modifying proteins or analogs thereof,...
US20120027814 Polymeric Fibers Having Tissue Reactive Members  
A method for bonding a polymeric fiber to tissue is provided which includes providing a polymeric fiber having a plurality of tissue reactive members linked to a surface of the fiber via a...
US20130064786 siRNA HYDROGEL AND METHOD FOR MANUFACTURING THE SAME  
The present invention relates to siRNA hydrogel and a method for manufacturing the same, and more particularly, to siRNA hydrogel for targeted gene silencing, which is nano-structured for targeted...
US20110200655 Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic  
A medical product is provided that is selected from at least one of, nasal cannulas, oxygen masks, wound dressings, bandages, band aids, catheters, endotrachial tubes, condoms, surgical and other...
US20130115165 Water-Dispersible Oral, Parenteral, and Topical Formulations for Poorly Water Soluble Drugs Using Smart Polymeric  
Polymeric nanoparticles with a hydrophobic core and a hydrophilic shell are formed from: 1) N-isopropylacrylamide (NIPAAM), at a molar ratio of about 50% to about 90%, and preferably 60% for...
US20110159062 ANTISEPTIC COMPOSITIONS AND USES THEREOF  
Antiseptic compositions and kits containing a source of silver ions and menthol, which act in synergy such that a concentration of silver ions in the composition is substantially reduced, are...
US20100015083 Method of producing pvp/fullerene complex and aqueous solution thereof  
An aromatic hydrocarbon solution of a fullerene or a fullerene mixture is mixed with an ethanol solution of polyvinylpyrrolidone (PVP), water is added to the mixed solution, the solvent is removed...
US20110250149 Tiotropium Bromide Having a Low Degree of Crystallinity  
The present invention provides tiotropium bromide having a low degree of crystallinity. The present invention also provides a complex of tiotropium bromide and polyvinylpyrrolidone, processes for...
US20120301530 COMPOSITIONS AND METHODS FOR ANTIMICROBIAL METAL NANOPARTICLES  
Embodiments of the invention are directed to a composition having antimicrobial activity comprising particles comprising at least one inorganic copper salt; and at least one functionalizing agent...
US20080072640 Insecticidal Fertilizer Solids and Method of Preparation  
An insecticidal fertilizer composition is prepared by contacting a solid fertilizer with a solution of a nicotinyl insecticide. The nicotinyl insecticide solution can be imidacloprid in a solvent,...
US20110165114 DRUG DELIVERY COMPOSITION  
There is provided a non-water soluble drug delivery composition comprising a conjugate and a polymer matrix wherein exposure of the composition to electromagnetic radiation at a suitable...
US20120052042 AMPHIPHILIC COMPOUNDS AND SELF-ASSEMBLING COMPOSITIONS MADE THEREFROM  
The present disclosure relates to amphiphilic compounds, self assembling compositions formed from the amphiphilic compounds and methods of making such compositions.
US20110020422 Hydroxyapatite-Targeting Poly(ethylene glycol) and Related Polymers  
Isolatable, hydroxyapatite-targeting polymeric structures, and biologically active conjugates thereof, are provided. The polymeric structure includes a linear or branched water-soluble and...
US20110135571 HYBRID NANOPARTICLES AS ANTI-CANCER THERAPEUTIC AGENTS AND DUAL THERAPEUTIC/IMAGING CONTRAST AGENTS  
The presently disclosed subject matter provides nanoscale coordination polymers for use as anticancer agents and as dual anticancer/imaging agents. The nanoscale coordination polymers can comprise...
US20140046279 Method for preventing the crystallisation of pharmaceuticals in a polymer film  
The invention relates to a method for preventing the crystallization of a pharmaceutical in a polymer film, wherein the solvent-containing coating compound, which comprises a matrix-forming...
US20150166706 NITRIC OXIDE-RELEASING DIAZENIUMDIOLATED POLYVINYLPYRROLIDONE-BASED POLYMERS, AND COMPOSITIONS, MEDICAL DEVICES, AND USES THEREOF  
Disclosed is a nitric oxide-releasing polyvinylpyrrolidone-based polymer derived from N-vinylpyrrolidone monomer and at least one nitric oxide releasing N2O2− group, in which the N2O2− group is...
US20150037275 RIFAXIMIN COMPLEXES  
There is provided a complex comprising rifaximin and a complexing agent, wherein the complexing agent is a polyvinyl pyrrolidone (PVP) or a cyclodextrin. There is also provided a process for...
US20110262378 Rifaximin Complexes  
There is provided a complex comprising rifaximin and a complexing agent, wherein the complexing agent is a polyvinyl pyrrolidone (PVP) or a cyclodextrin. There is also provided a process for...
US20120195847 POLYMER CONJUGATES OF BIPHALIN PEPTIDES  
The invention provides peptides that are chemically modified by covalent attachment of a water soluble oligomer. A conjugate of the invention, when administered by any of a number of...
US20130160761 Pharmaceutical Aerosol Composition  
A pharmaceutical aerosol composition comprising at least one hydrofluoroalkane propellant; at least one active agent complexed with an adjuvant; and, optionally, at least one pharmaceutically...

Matches 1 - 23 out of 23